{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT01809769",
      "OrgStudyIdInfo": {
        "OrgStudyId": "CBMG-KOA-1.1"
      },
      "Organization": {
        "OrgFullName": "Cellular Biomedicine Group Ltd.",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "Autologous Adipose Tissue Derived Mesenchymal Stem Cells Therapy for Patients With Knee Osteoarthritis",
      "OfficialTitle": "Autologous Adipose Tissue Derived Mesenchymal Stem Cells Therapy for Patients With Knee Osteoarthritis by Intra-articular Injection: A PhaseⅠ/Ⅱa, Randomized and Double-blinded Clinical Trial"
    },
    "StatusModule": {
      "StatusVerifiedDate": "April 2016",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "March 2013"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "March 2015",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "July 2015",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "March 11, 2013",
      "StudyFirstSubmitQCDate": "March 11, 2013",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "March 13, 2013",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "April 1, 2016",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "April 4, 2016",
        "LastUpdatePostDateType": "Estimate"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Cellular Biomedicine Group Ltd.",
        "LeadSponsorClass": "INDUSTRY"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "RenJi Hospital",
            "CollaboratorClass": "OTHER"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "Two injections in total and 3 ml autologous adipose-tissue-derived stem cells(haMSCs) for each injection; time-points for intervention: 1) initial injection; 2) 3 weeks following initial injection.",
      "DetailedDescription": "Adipose (fat) tissue is removed by lipo-aspiration (this may take up to 40 minutes). The fat is processed on-site to isolate and obtain the MSCs,then proliferate them. The suspension of the cells is injected into the knee joint under ultrasound guidance. (about 20 minutes)."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Knee Osteoarthritis"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1",
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "Double",
          "DesignWhoMaskedList": {
            "DesignWhoMasked": [
              "Participant",
              "Investigator"
            ]
          }
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "18",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Mesenchymal stem cells low-dose group",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Biological: Mesenchymal progenitor cells. Administrated for intra-articular use. Dosage: 1 x 10 E7 cells (3 ml), Frequency: 0,3 weeks.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Mesenchymal stem cells low-dose group"
              ]
            }
          },
          {
            "ArmGroupLabel": "Mesenchymal stem cells mid-dose group",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Biological: Mesenchymal progenitor cells. Administrated for intra-articular use. Dosage: 2 x 10 E7 cells (3 ml). Frequency: 0,3 weeks.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Mesenchymal stem cells mid-dose group"
              ]
            }
          },
          {
            "ArmGroupLabel": "Mesenchymal stem cells high-dose group",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Biological: Mesenchymal progenitor cells. Administrated for intra-articular use. Dosage:5 x 10 E7 cells (3 ml). Frequency: 0,3 weeks.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Mesenchymal stem cells high-dose group"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Mesenchymal stem cells low-dose group",
            "InterventionDescription": "Biological: Adipose tissue derived mesenchymal stem cells administrated for intra-articular use",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Mesenchymal stem cells low-dose group"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "Adipose tissue derived mesenchymal stem cells"
              ]
            }
          },
          {
            "InterventionType": "Biological",
            "InterventionName": "Mesenchymal stem cells mid-dose group",
            "InterventionDescription": "Biological: Adipose tissue derived mesenchymal stem cells administrated for intra-articular use",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Mesenchymal stem cells mid-dose group"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "Adipose tissue derived mesenchymal stem cells"
              ]
            }
          },
          {
            "InterventionType": "Biological",
            "InterventionName": "Mesenchymal stem cells high-dose group",
            "InterventionDescription": "Biological: Adipose tissue derived mesenchymal stem cells administrated for intra-articular use",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Mesenchymal stem cells high-dose group"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "Adipose tissue derived mesenchymal stem cells"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Recording of Adverse Events and Serious Adverse Events",
            "PrimaryOutcomeTimeFrame": "12 weeks"
          },
          {
            "PrimaryOutcomeMeasure": "Electrocardiogram",
            "PrimaryOutcomeTimeFrame": "9 weeks"
          },
          {
            "PrimaryOutcomeMeasure": "Vital signs",
            "PrimaryOutcomeTimeFrame": "9 weeks"
          },
          {
            "PrimaryOutcomeMeasure": "Physical examination",
            "PrimaryOutcomeTimeFrame": "9 weeks"
          },
          {
            "PrimaryOutcomeMeasure": "WOMAC Score(The Western Ontario and McMaster Universities Osteoarthritis Index)",
            "PrimaryOutcomeTimeFrame": "24 months"
          },
          {
            "PrimaryOutcomeMeasure": "Laboratory tests",
            "PrimaryOutcomeDescription": "Routine blood and urine tests, hepatic and renal functions tests, blood lipid and glucose tests, immunologic tests",
            "PrimaryOutcomeTimeFrame": "9 weeks"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "SF-36",
            "SecondaryOutcomeTimeFrame": "24 months"
          },
          {
            "SecondaryOutcomeMeasure": "NRS-11",
            "SecondaryOutcomeTimeFrame": "24 months"
          },
          {
            "SecondaryOutcomeMeasure": "The volume of articular cartilage",
            "SecondaryOutcomeTimeFrame": "24 months"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nSubjects who understand and sign the consent form for this study.\nAge: 40-70, males and females.\nClinical diagnosis of degenerative arthritis by Radiographic Criteria of Kellgren and Lawrence.\nPatients who can't treat with traditional medication and need a arthroplasty.\nDuration of pain over Grade 4(11-point numeric scale)> 4 months.\n\nExclusion Criteria:\n\nWomen who are pregnant or breast feeding or planning to become pregnant during the study.\nObjects who administer with a anti-inflammatory drugs within 14 days prior to inclusion in the study.\nHistory or current evidence of alcohol or drug abuse or is a recreational user of illicit drugs or prescription medications.\nTreatment with intra-articular injection therapy within 2 months prior to screen.\nOther joint diseases except degenerative arthritis : systemic or rheumatic or inflammatory chondropathy, chondrocalcinosis, hemachromatosis, inflammatory joint disease, avascular necrosis of the femoral head, Paget's disease, hemophilic arthropathy, infectional arthritis, Charcot's disease, villonodular synovitis, synovial chondromatosis.\nPositive serology for HIV-1 or HIV-2, Hepatitis B (HBsAg, Anti-HCV-Ab), Hepatitis C (Anti-HCV-Ab) and syphilis.\nSerious pre-existing medical conditions like Cardiovascular Diseases, Renal Diseases, Liver Diseases, Endocrine Diseases, Cancer and Diabetes Mellitus.\nOverweight expressed as body mass index (BMI) greater than 30 (obesity grade II).\nParticipation in another clinical trial or treatment with a different investigational product within 3 months prior to inclusion in the study.\nOther pathologic conditions or circumstances that difficult participation in the study according to medical criteria.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "40 Years",
      "MaximumAge": "70 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Chunde Bao, M.D. & Ph.D.",
            "OverallOfficialAffiliation": "Department of Rheumatology,Ren Ji Hospital,School of Medicine,Shanghai Jiao Tong University,Shanghai,China",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Department of Rheumatology,Ren Ji Hospital,School of Medicine,Shanghai Jiao Tong University,Shanghai,China",
            "LocationCity": "Shanghai",
            "LocationState": "Shanghai",
            "LocationZip": "200127",
            "LocationCountry": "China"
          }
        ]
      }
    },
    "ReferencesModule": {
      "ReferenceList": {
        "Reference": [
          {
            "ReferencePMID": "29417902",
            "ReferenceType": "derived",
            "ReferenceCitation": "Song Y, Du H, Dai C, Zhang L, Li S, Hunter DJ, Lu L, Bao C. Human adipose-derived mesenchymal stem cells for osteoarthritis: a pilot study with long-term follow-up and repeated injections. Regen Med. 2018 Apr;13(3):295-307. doi: 10.2217/rme-2017-0152. Epub 2018 Feb 8."
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000010003",
            "ConditionMeshTerm": "Osteoarthritis"
          },
          {
            "ConditionMeshId": "D000020370",
            "ConditionMeshTerm": "Osteoarthritis, Knee"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000001168",
            "ConditionAncestorTerm": "Arthritis"
          },
          {
            "ConditionAncestorId": "D000007592",
            "ConditionAncestorTerm": "Joint Diseases"
          },
          {
            "ConditionAncestorId": "D000009140",
            "ConditionAncestorTerm": "Musculoskeletal Diseases"
          },
          {
            "ConditionAncestorId": "D000012216",
            "ConditionAncestorTerm": "Rheumatic Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M12078",
            "ConditionBrowseLeafName": "Osteoarthritis",
            "ConditionBrowseLeafAsFound": "Osteoarthritis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M21321",
            "ConditionBrowseLeafName": "Osteoarthritis, Knee",
            "ConditionBrowseLeafAsFound": "Knee Osteoarthritis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M3628",
            "ConditionBrowseLeafName": "Arthritis",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9773",
            "ConditionBrowseLeafName": "Joint Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11249",
            "ConditionBrowseLeafName": "Musculoskeletal Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14197",
            "ConditionBrowseLeafName": "Rheumatic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5475",
            "ConditionBrowseLeafName": "Collagen Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC05",
            "ConditionBrowseBranchName": "Musculoskeletal Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC17",
            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
          }
        ]
      }
    }
  }
}